Biochemical characterization and immunohistochemical localization of urotensin II in the human brainstem and spinal cord

Journal of Neurochemistry

Volumn 91, Issue 1, 2004, Pages 110-118

  Chartrel, Nicolas ^a   Leprince, Jérôme ^a   Dujardin, Cynthia ^a   Chatenet, David ^a   Tollemer, Hélène ^a   Baroncini, Marc ^b   Balment, Richard J ^c   Beauvillain, Jean Claude ^d   Vaudry, Hubert ^a  

^a UNIVERSITÉ DE ROUEN   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d Inst Federatif de Rech No 17   (France)

Author keywords

Central nervous system; Motoneurones; Neuropeptides; Precursor; Processing

Indexed keywords

UROTENSIN II;

AGED; ARTICLE; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOTONEURON; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SPINAL CORD; SPINAL CORD VENTRAL HORN;

AGED; AGED, 80 AND OVER; ANIMALS; BRAIN CHEMISTRY; BRAIN STEM; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; PEPTIDE FRAGMENTS; PEPTIDE HORMONES; POSTMORTEM CHANGES; RADIOIMMUNOASSAY; SPINAL CORD; UROTENSINS;

EID: 4744362370     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02698.x     Document Type: Article

References (58)

1. Ames R. S., Sarau H. M., Chambers J. K. et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the receptor GPR 14. Nature 401, 282-286.
2. Behm D. J., Harrison S. M., Ao Z. et al. (2003) Deletion of the UT receptor gene results in the selective loss of urotensin-II contractile activity in aortae islated from UT receptor knock out mice. Br. J. Pharmacol. 139, 464-472.
3. Bern H. A., Pearson D., Larson B. A. and Nishioka R. S. (1985) Neurohormone from fish tails: the caudal neurosecretory system. ≪ Urophysiology ≫ and the caudal neurosecretory system of fishes. Rec. Prog. Horm. Res. 41, 533-552.
4. Brailoiu E., Brailoiu G. C., Miyamoto M. D. and Dun N. J. (2003) The vasoactive peptide urotensin II stimulates spontaneous release from frog motor nerve terminal. Br. J. Pharmacol. 138, 1580-1588.
5. Brazeau P., Vale W., Burgus R., Butcher M., Rivier J. and Guillemin R. (1973) Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179, 77-79.
6. Changeux J. P., Duclert A. and Sekine S. (1992) Calcitonin gene-related peptides and neuromuscular interactions. Ann. N.Y. Acad. Sci. 657, 361-378.
7. Chartrel N., Conlon J. M., Collin F., Braun B., Waugh D., Vallarino M., Lahrichi S. L., Rivier J. E. and Vaudry H. (1996) Urotensin II in the central nervous system of the frog Rana ridibunda: immunohistochemical and biochemical characterization. J. Comp. Neurol. 364, 324-339.
8. Chartrel N., Dujardin C., Anouar Y. et al. (2003) Identification of 26RFa, a hypothalamic neuropeptide of the RFamide peptide family with orexigenic activity. Proc. Natl Acad. Sci. USA 100, 15247-15252.
9. Conlon J. M., Arnold-Reed D. and Balment R. J. (1990) Post-translational processing of prepro-urotensin II. FEBS Lett. 266, 37-40.
10. Conlon J. M., O'Harte F., Smith D. D., Tonon M. C. and Vaudry H. (1992) Isolation and primary structure of urotensin II from the brain of a tetrapod, the frog Rana ridibunda. Biochem. Biophys. Res. Commun. 188, 578-583.
11. Conlon J. M., Tostivint H. and Vaudry H. (1997) Somatostatin and urotensin II-related peptides: molecular diversity and evolutionary perspectives. Regul. Peptides 69, 95-103.
12. Coulouam Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J. C., Conlon J. M., Bern H. A. and Vaudry H. (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in the motoneurons of the spinal cord. Proc. Natl Acad. Sci. USA 95, 15803-15808.
13. Coulouarn Y., Jegou S., Tostivint H., Vaudry H. and Lihrmann I. (1999) Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett. 457, 28-32.
14. Coulouarn Y., Fernex C., Jegou S., Henderson C. E., Vaudry H. and Lihrmann I. (2001) Specific expression of urotensin II gene in sacral motoneurons of developing rat spinal cord. Mech. Dev. 101, 187-190.
15. Douglas S. A. (2003) Human urotensin-II as a novel cardiovascular target: 'heart' of the matter or simply a fishy 'tail'? Curr. Opin. Pharmacol. 3, 1-9.
16. Douglas S. A., Sulpizio A. C., Piercy V., Sarau H. M., Ames R. S., Aiyar N. V., Ohlstein E. H. and Willette M. R. (2000) Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey. Br. J. Pharmacol. 131, 1262-1274.
17. Douglas S. A., Tayara L., Ohlstein E. H., Halawa N. and Giaid A. (2002) Congestive heart failure and expression of myocardial urotensin II. Lancet 359, 1990-1997.
18. Dun S. L., Brailoiu G. C., Yang J., Chang J. K. and Dun N. J. (2001) Urotensin II immunoreactivity in the brainstem and spinal cord of the rat. Neurosci. Lett. 305, 9-12.
19. Elshourbagy N. A., Douglas S. A., Shabon U. et al (2002) Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from mouse and monkey. Br. J. Pharmacol. 136, 9-22.
20. Eritja R., Ziehler-Martin J. P., Walker P. A., Lee T. D., Legesse K., Albericio F. and Kaplan B. E. (1987) On the use of S-t-butyl sulphenyl group for protection of cysteine in solid-phase peptide synthesis using Fmoc-amino acids. Tetrahedron 43, 2675-2680.
21. Esch F., Bohlen P., Ling N., Benoit R., Brazeau P. and Guillemin R. (1980) Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25. Proc. Natl Acad. Sci. USA 77, 6827-6831.
22. Ferrero P., Santi M. R., Conti-Tronconi B., Costa E. and Guidotti A. (1986) Study of an octadecaneuropeptide derived from diazepam binding inhibitor (DBI): biological activity and presence in rat brain. Proc. Natl Acad. Sci. USA 83, 827-831.
23. Filipeanu C. M., Brailoiu E., Dun S. L. and Dun N. J. (2002) Urotensin-II regulates intracellular calcium in dissociated rat spinal cord neurons. J. Neurochem. 83, 879-884.
24. Flohr S., Kurz M., Kostenis E., Brkovich A., Fournier A. and Klabunde T. (2002) Identification of nonpeptidic urotensin II receptor antagonists by virtual screening based on a pharmacophore model derived from structure activity relationships and nuclear magnetic resonance studies on urotensin II. J. Med. Chem. 45, 1799-1805.
25. Ichikawa T., Lederis K. and Kobayashi H. (1984) Primary structure of multiple forms of urotensin II in the urophysis of the carp, Cyprinus carpio. Gen. Comp. Endocrinol. 55, 133-141.
26. Jeandel L., Yon L., Chartrel N., Gonzalez B., Fournier A., Conlon J. M. and Vaudry H. (1999) Characterization and localization of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites in the brain of the frog Rana ridibunda. J. Comp. Neurol. 412, 218-228.
27. Jiang Y., Luo L., Gustafson E. L. et al. (2003) Identification and characterization of a novel RFamide peptide ligand for orphan G-protein-coupled receptor SP9155. J. Biol. Chem. 278, 27652-27657.
28. Kanetoh T., Sugikawa T., Sasaki I., Muneoka Y., Minakata H., Takabatake I. and Fujimoto M. (2003) Identification of a novel RFamide and its effect on the latency of the tail-flick response of the newt. Comp. Biochem. Physiol. 134, 259-266.
29. Kinney W. A., Almond H. R., Qi J. et al. (2002) Structure-function analysis of urotensin II and its use in the construction of a ligand-receptor working model. Angew. Chem. Int. Ed. Engl. 41, 2940-2944.
30. Kurz E. M., Sengelaub D. R. and Arnold A. P. (1986) Androgens regulate the dendritic length of mammalian motoneurons in adulthood. Science 232, 395-398.
31. Labarrère P., Chatenet D., Leprince J. et al. (2003) Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J. Enz. Inhib. Med. Chem. 18, 77-88.
32. Liu Q., Pong S. S., Zeng Z. et al. (1999) Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR 14. Biochem. Biophys. Res. Commun. 266, 174-178.
33. MacLean M. R., Alexander D., Stirrat A., Gallagher M., Douglas S. A., Ohlstein E. H., Morecroft I. and Polland K. (2000) Contractile responses to human urotensin-II in rat and human pulmonary arteries: effect of endothelial factors and chronic hypoxia in the rat. Br. J. Pharmacol. 130, 201-204.
34. Maguire J. J., Kuc R. E. and Davenport A. P. (2000) Orphan-receptor ligand human urotensin II: receptor localization in human tissues and comparison of vasoconstrictor responses with endothelin-1. Br. J. Pharmacol. 131, 441-446.
35. Masmoudi O., Gandolfo P., Leprince J., Vaudry D., Fournier A., Patte-Mensah C., Vaudry H. and Tonon M. C. (2003) Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates endozepine release from cultured rat astrocytes via a PKA-dependent mechanism. FASEB J. 17, 17-27.
36. Mori M., Sugo T., Abe M. et al. (1999) Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor SENR (GPR 14). Biochem. Biophys. Res. Commun. 265, 123-129.
37. Nordeen E. J., Nordeen K. W., Sengelaub D. R. and Arnold A. P. (1985) Androgens prevent normally occurring cell death in a sexual dimorphic spinal nucleus. Science 229, 671-673.
38. Nothacker H. P., Wang Z., McNeill A. M., Saito Y., O'Dowd B., Duckles S. P. and Civelli O. (1999) Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat. Cell Biol. 1, 383-385.
39. Ohsako S., Ishida I., Ichikawa T. and Deguchi T. (1986) Cloning and sequence analysis of cDNAs encoding precursors of urotensin II-α and -γ. J. Neurosci. 6, 2730-2735.
40. Pearson D., Shirely J. E., Clark B. R., Geschwind I. I., Barkley M., Nishioka R. S. and Bern H. A. (1980) Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc. Natl Acad. Sci. USA 11, 5021-5024.
41. Pelletier G., Lihrmann I. and Vaudry H. (2002) Role of androgens in the regulation of urotensin II precursor mRNA expression in the rat brainstem and spinal cord. Neuroscience 115, 525-532.
42. Pradayrol L., Jornvall H., Mutt V. and Ribet A. (1980) N-terminally extended somatostatin: the primary structure of somatostatin-28. FEBS Lett. 109, 55-58.
43. Rouillé Y., Duguay S. J., Lund K., Furuta M., Gong Q., Lipkind G., Oliva A. A., Chan S. J. and Steiner D. F. (1995) Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilin-like proprotein convertases. Front. Neuroendocrinol. 16, 322-361.
44. Rourke I. J., Johnsen A. H., Din N., Petersen J. G. L. and Rehfeld J. F. (1997) Heterologous expression of human cholecystokinin in Saccharomyces cerevisiae. J. Biol. Chem. 272, 9720-9727.
45. Satake H., Hisada M., Kawada T., Minakata H., Ukena K. and Tsutsui K. (2001) Characterization of a cDNA encoding a novel avian hypothalamic neuropeptide exhibiting an inhibitory effect on gonadotropin release. Biochem. J. 354, 379-385.
46. Seidah N. G., Day R., Marcinkiewicz M. and Chrétien M. (1998) Precursor convertases: an evolutionary ancient, cell specific, combinatorial mechanism yielding diverse bioactive peptides and proteins. Ann. N.Y. Acad. Sci. 839, 9-24.
47. Steiner D. F., Smeekens S. P., Ohagi S. and Chan S. J. (1992) The new enzymology of precursor processing endoproteases. J. Biol. Chem. 267, 23435-23438.
48. Sugo T., Murakami Y., Shimomura Y. et al. (2003) Identification of urotensin II-related peptide as the urotensin-immunoreactive molecule in the rat brain. Biochem. Biophys. Res. Commun. 310, 860-868.
49. Takahashi K., Totsune K., Murakami O. and Shibahara S. (2001) Expression of urotensin II and urotensin II receptor mRNAs in various tumor cell lines and secretion of urotensin II-like immunoreactivity by SW-13 adrenocortical carcinoma cells. Peptides 22, 1175-1179.
50. Totsune K., Takahashi K., Arihara Z., Sone M., Satoh F., Ito S., Kimura Y., Sasano H. and Murakami O. (2001) Role of urotensin II in patients on dialysis. Lancet 358, 810-811.
51. Tzanidis A., Hannan R. D., Thomas W. G., Onan D., Autelitano D. J., See F., Kelly D. J., Gilbert R. E. and Krum H. (2003) Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ. Res. 93, 246-253.
52. Vaudry H., Tonon M. C., Delarue C., Vaillant R. and Kraicer J. (1978) Biological and radioimmunological evidence for melanocyte-stimulating hormones (MSH) of extrapituitary origin in the rat brain. Neuroendocrinology 27, 9-24.
53. Viereck J. C. and Beinfeld M. C. (1992) Characterization of a cholecystokinin 8-generating endoprotease purified from rat brain synaptosomes. J. Biol. Chem. 267, 19475-19481.
54. Watanabe T., Pakala R., Katagiri T. and Benedict C. R. (2001) Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104, 16-18.
55. Wilkinson I. B., Affolter J. T., de Haas S. L., Pellegrini M. P., Boyd J., Winter M. J., Balment R. J. and Webb D. J. (2002) High plasma concentrations of human urotensin II do not alter local systemic hemodynamics in man. Cardiovasc. Res. 53, 341-347.
56. Winter M. J., Hubbard P. C., McCrohan C. R. and Balment R. J. (1999) A homologous radioimmunoassay for the measurement of urotensin II in the Euryhaline flounder, Platichthys flesus. Gen. Comp. Endocrinol. 114, 249-256.
57. Yu W. A. (1989) Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem nuclei of female rats. J. Neurosci. 9, 3908-3914.
58. Zou Y., Nagai R. and Yamazaki T. (2001) Urotensin II induces hypertrophic responses in cultured cardiomyocytes from neonatal rats. FEBS Lett. 508, 57-60.